Form 4: Hayward Holdings CEO Trades Shares Under 10b5-1 Plan

Hayward Holdings CEO Kevin Holleran executed trades involving company stock, acquiring and selling shares under pre-established Rule 10b5-1 plans.

Summary

• Kevin Holleran, President and CEO of Hayward Holdings, Inc., reported transactions involving the company's common stock.
• On June 30, 2026, Holleran acquired 50,000 shares at $1.40 per share under a Rule 10b5-1 plan and sold 50,000 shares at a weighted average price of $17.07.
• On July 1, 2026, Holleran acquired an additional 120,000 shares at $1.40 per share under a separate Rule 10b5-1 plan and sold 120,000 shares at a weighted average price of $17.28.
• Following these transactions, Holleran beneficially owns 701,234 shares directly and 700 shares indirectly through a child.
• The transactions were executed under Rule 10b5-1 trading plans adopted on August 18, 2025, and March 10, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While the CEO is selling a significant number of shares, the transactions are conducted under a pre-established 10b5-1 plan, mitigating concerns of opportunistic insider selling. The simultaneous acquisition of shares at a lower price adds a layer of complexity.

Positives

• The transactions were conducted under pre-arranged Rule 10b5-1 plans, indicating a structured approach to managing personal stock holdings and avoiding insider trading concerns.
• The acquisition of shares at a lower price ($1.40) suggests potential for future appreciation or a strategic investment by the CEO.
• The CEO continues to hold a significant number of shares (701,234 directly) after the sales, indicating continued confidence in the company.

Negatives

• The CEO sold a substantial number of shares (170,000 in total) on consecutive days.
• The sale prices, while higher than the acquisition price, represent a significant divestment of holdings.

Risks

• Potential for negative market perception due to the CEO selling a large volume of shares, even if executed under a plan.
• The weighted average sale prices indicate a range of selling prices, with some shares sold at lower prices within that range.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance. However, the CEO's acquisition of shares at $1.40 under a 10b5-1 plan could imply a belief in future value appreciation.

Management Comments

• The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 18, 2025.
• The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2026.
• The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $17.000 to $17.1450, inclusive.
• The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $17.0600 to $17.4050, inclusive.

Industry Context

StockSavvy.ai notes that the use of Rule 10b5-1 plans by executives is a common practice to diversify or monetize holdings while adhering to insider trading regulations. The specific prices at which shares were acquired and sold provide insight into the CEO's cost basis and the market valuation at the time of the transactions.

Stakeholder Impact

• Shareholders may interpret the CEO's sale of shares as a negative signal, despite the Rule 10b5-1 plan, potentially impacting share price.

Key Dates

Recommendation

The filing details routine stock transactions by the CEO under a Rule 10b5-1 plan. While the sale of a significant number of shares could be a concern, the structured nature of the plan and the simultaneous acquisition of shares at a lower price suggest a balanced approach rather than a strong conviction to exit. Therefore, a 'hold' recommendation is appropriate pending further fundamental analysis of the company's performance.

Keywords

Hayward Holdings, HAYW, Form 4, Insider Trading, Rule 10b5-1, Stock Transaction, CEO, Kevin Holleran, Beneficial Ownership, Securities Exchange Act